Surgery Partners, Inc. (SGRY): Price and Financial Metrics


Surgery Partners, Inc. (SGRY)

Today's Latest Price: $17.84 USD

0.23 (-1.27%)

Updated Jan 27 4:00pm

Add SGRY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 66 in Medical - Services

See all "A" rated Strong Buy stocks

SGRY Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for SGRY is 5.41 -- better than 92.26% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 13.05 for Surgery Partners Inc; that's greater than it is for 96.69% of US stocks.
  • In terms of volatility of its share price, SGRY is more volatile than 91.24% of stocks we're observing.
  • Stocks that are quantitatively similar to SGRY, based on their financial statements, market capitalization, and price volatility, are CDOR, NS, INAP, WHLR, and SALM.
  • Visit SGRY's SEC page to see the company's official filings. To visit the company's web site, go to www.surgerypartners.com.
SGRY Daily Price Range
SGRY 52-Week Price Range

SGRY Stock Price Chart More Charts


SGRY Price/Volume Stats

Current price $17.84 52-week high $18.89
Prev. close $18.07 52-week low $5.38
Day low $17.45 Volume 484,351
Day high $18.14 Avg. volume 453,335
50-day MA $15.09 Dividend yield N/A
200-day MA $10.03 Market Cap 891.98M

Surgery Partners, Inc. (SGRY) Company Bio


Surgery Partners Inc. is a healthcare services company focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of the company's patients and physicians. The company was founded in 2004 and is based in Nashville, Tennessee.

SGRY Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$17.84$14.65 -19%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Surgery Partners Inc. To summarize, we found that Surgery Partners Inc ranked in the 53st percentile in terms of potential gain offered. The most interesting components of our discounted cash flow analysis for Surgery Partners Inc ended up being:

  • 26% of the company's capital comes from equity, which is greater than only 7.15% of stocks in our cash flow based forecasting set.
  • Surgery Partners Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.05. This coverage rate is greater than that of merely 17.38% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Surgery Partners Inc experienced a tax rate of about 176% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 97.51% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-21%
1%-20%
2%-19%
3%-18%
4%-17%
5%-17%

LH, ARWR, DGX, AMGN, and FTLF can be thought of as valuation peers to SGRY, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.





SGRY Latest News Stream


Event/Time News Detail
Loading, please wait...

SGRY Latest Social Stream


Loading social stream, please wait...

View Full SGRY Social Stream

SGRY Price Returns

1-mo 14.95%
3-mo 125.82%
6-mo 133.81%
1-year 37.23%
3-year -3.83%
5-year N/A
YTD 13.96%
2019 59.91%
2018 -19.09%
2017 -23.66%
2016 -22.65%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7346 seconds.